FRCSC

ARC Fertility Teams Up with Leapfrog for High-Value Family-Forming Benefits Webinar, Invites Self Insurance Stakeholders to Attend

Retrieved on: 
Tuesday, March 5, 2024
Other Health, LGBTQ+, Professional Services, Family, Data Management, Consumer, Technology, Parenting, Baby, Maternity, Insurance, Women, Finance, Health, FACS, American Medical Women's Association, ROI, ARC, Fertility, FRCSC, Consultant, CFOS, FACOG, AMWA, Languages of Ethiopia, MPH, Patient safety, Publication, VOI, Face, Partnership, Management

In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.

Key Points: 
  • In collaboration with Leapfrog , this webinar is a testament to Leapfrog's dedication to fostering industry dialogue through its Partner Advisory Committee (PAC) where ARC Fertility is a proud member.
  • David Adamson, MD, FRCSC, FACOG, FACS, Founder and CEO, ARC Fertility, and Eliza Chin, MD, MPH, Executive Director, American Medical Women's Association (AMWA), will lead the discussion.
  • ARC Fertility is set to guide CEOs, CFOs and corporate human resources (CHRs) through the intricate landscape of family-forming benefits.
  • Drawing from our experience, we will explore the challenges employers face and the benefits of a flexible and affordable family-forming benefits solution.

Limmi appoints nationally recognized cancer researcher, Dr. Kader, to its Board of Directors

Retrieved on: 
Tuesday, March 5, 2024
Advisory board, Doctor of Philosophy, MD, Urinary diversion, Bladder cancer, FRCSC, Genomics, Risk, Patient, Big data, UC San Diego Health, Deep learning, UCSD, Prostate cancer, Pharmaceutical industry

"We're in a desperate need at this time for solutions like the one Limmi is offering.

Key Points: 
  • "We're in a desperate need at this time for solutions like the one Limmi is offering.
  • states Professor Kader , and continues, "As a surgeon scientist, I made a discovery regarding genetic risk in prostate cancer.
  • In addition to being a board-certified urologist who specializes in detecting, treating, and preventing prostate cancer, Dr. Kader is nationally recognized for his expertise in performing robot-assisted radical cystectomy and urinary diversion for patients with bladder cancer.
  • He holds several patents for genetic discoveries related to early detection of prostate cancer.

Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, Named First Vice President of the American Academy of Orthopaedic Surgeons

Retrieved on: 
Wednesday, February 14, 2024
SAN, Humility, Ankle, ISAKOS, Orthopaedic sports medicine, Research, MD, Knee, Foot, FRCSC, International Society, Royal college, Annual general meeting, Faculty, University, Duke, Duke University, Sports medicine, AAOS, American Academy, Dentistry

SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- North Carolina orthopaedic surgeon Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, division chief for sports medicine at Duke University, was named first vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.

Key Points: 
  • SAN FRANCISCO, Feb. 14, 2024 /PRNewswire/ -- North Carolina orthopaedic surgeon Annunziato (Ned) Amendola, MD, FAAOS, FRCSC, DABOS, division chief for sports medicine at Duke University, was named first vice president of the American Academy of Orthopaedic Surgeons' (AAOS) Board of Directors.
  • He will assume the first vice president position following the AAOS 2024 Annual Meeting this week in San Francisco.
  • He received several orthopaedic research awards, including the Excellence in Research Award, the Cabaud Memorial Award and the O'Donoghue Award.
  • While there, he held the Kim and John Callaghan Endowed Chair in Sports Medicine before leaving for Duke University.

Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage

Retrieved on: 
Thursday, February 8, 2024
Technology, Hospitals, FDA, Health Technology, Cardiology, Software, Practice Management, Health, Data Management, Artificial Intelligence, Radiology, Viz, Neurology, Brain, FRCSC, NCCT, Food, Food and Drug Administration, ICH, AI, University, UTHealth School of Dentistry, MPH, Multimedia, Neurosurgery, Hospital, Stroke, Lateral ventricles, Disease, Intracerebral hemorrhage

“This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."

Key Points: 
  • “This technology, which marries precision with AI, is poised to transform how we approach intracerebral hemorrhage cases."
  • Intracerebral hemorrhage accounts for up to 15% of all strokes and has high morbidity and mortality rates, demanding swift response.
  • Accurate volume measurements of brain bleeds are crucial for assessing the severity of cases, monitoring progression, and planning treatment strategies.
  • Viz ICH Plus exemplifies our dedication to enhancing patient care by leveraging technology," stated Jayme Strauss, chief clinical officer at Viz.ai.

Glaucoma Innovations to be Presented at 13th Annual New Horizons Forum in San Francisco

Retrieved on: 
Tuesday, January 16, 2024
Optometry, Stanford University, Patient, GRF, Forum, Ophthalmology, SAN, Multimedia, Green, DRS, American Glaucoma Society, University, MBA, Bachelor of Science, University of Utah, Glaucoma, FDA, Harvard University, Doctor of Philosophy, MPH, FRCSC

SAN FRANCISCO, Jan. 16, 2024 /PRNewswire/ -- Glaucoma Research Foundation (GRF) will host the 13th Annual Glaucoma 360 New Horizons Forum on February 9th at San Francisco's historic Westin St. Francis Hotel.

Key Points: 
  • SAN FRANCISCO, Jan. 16, 2024 /PRNewswire/ -- Glaucoma Research Foundation (GRF) will host the 13th Annual Glaucoma 360 New Horizons Forum on February 9th at San Francisco's historic Westin St. Francis Hotel.
  • Dr. Ianchulev's keynote lecture "The Innovation Journey of an iDoctor" will shed light on recent and on-the-horizon advances in glaucoma care.
  • The complete program agenda can be viewed on the New Horizons Forum website .
  • New Horizons Forum is the centerpiece of Glaucoma 360 , GRF's signature three-day series of events planned for February 8 to 10, 2024.

Children’s Hospital Los Angeles Researchers Develop Clinical Tool to Predict if a Child in Acute Liver Failure Will Need a Transplant

Retrieved on: 
Monday, October 23, 2023
Software, Research, Internet, Family, Consumer, Apps, Applications, Technology, Hospitals, Children, Science, Surgery, Health, Liver injury, Child, Children's Hospital Los Angeles, PELD, Smartphone, Liver, MD, USC, Viral hepatitis, Cirrhosis, Doctor of Philosophy, FRCSC, MBBS, Immune-mediated inflammatory diseases, FACS, King's College Hospital NHS Foundation Trust, Division, Chronic liver disease, Risk, National Cancer Institute, CHLA, Nutrition, Probability, King's College Hospital, Hepatotoxicity, Liver failure, NIH, MHA, Hospital, Patient, Transplant, Acute liver failure, Diagnosis, Death, MS, Dietary supplement, Birth control, Gastroenterology

Unlike children with chronic liver disease, previously healthy children who develop acute liver failure can suddenly deteriorate.

Key Points: 
  • Unlike children with chronic liver disease, previously healthy children who develop acute liver failure can suddenly deteriorate.
  • While pediatric acute liver failure has been linked to both viral hepatitis and drug-induced liver injury, at least half of cases have no apparent trigger.
  • The CHALF Score predicts if a child experiencing acute liver failure will recover or should be referred to a transplant center.
  • Doctors do not want to refer a child for liver transplant who could otherwise recover with medical treatment—about 70% of children with acute liver failure recover while keeping their original liver.

Studies Investigate the Impact of Obesity on Outcomes after the Total Ankle Replacement (TAR) Procedure

Retrieved on: 
Tuesday, October 17, 2023
Foot, BMI, Pain, DRS, SAGE Publishing, Hip, Division, Obesity, American Orthopaedic Foot and Ankle Society, United Kingdom, ST, MD, Risk, Duke, BMI Healthcare, Failure, FAI, FRCSC, Orthopedic surgery, TAR, Patient, Literature, Duke University, Surgeon, Ankle, Body mass index, Medical device, Pharmaceutical industry

Rosemont, Ill., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Total Ankle Replacement (TAR), also known as total ankle arthroplasty, is a surgical procedure that foot and ankle orthopaedic surgeons use to treat ankle arthritis.

Key Points: 
  • Rosemont, Ill., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Total Ankle Replacement (TAR), also known as total ankle arthroplasty, is a surgical procedure that foot and ankle orthopaedic surgeons use to treat ankle arthritis.
  • Foot and ankle orthopaedic surgeons continue to investigate the factors that contribute to the success or failure of the procedure, including the impact of obesity.
  • The study titled “Total Ankle Arthroplasty: Does Obesity Matter?” reviewed data from 1,093 patients who underwent TAR at Duke between 2001 and 2020.
  • This is one of the largest single-institution studies to date examining the effect of obesity on outcomes after TAR.

CLINIQUE WELCOMES DR. ASHLEY BRISSETTE AS BRAND'S FIRST GUIDING OPHTHALMOLOGIST

Retrieved on: 
Wednesday, August 23, 2023
FRCSC, Partnership, Senior, Education, Cataract, Consultant, NHL, American Academy, American Academy of Ophthalmology, Science, Patient, Master of Science, Safety, Distribution (marketing), Cosmetics, Clinique, Ophthalmology, MD

NEW YORK, Aug. 23, 2023 /PRNewswire/ -- With over five decades rooted in safety, Clinique, a dermatologist-developed prestige beauty brand, announces Ashley Brissette, MD, MSc, FRCSC, as the brand's first guiding ophthalmologist. In the newly created role, Dr. Brissette, a leading NYC-based ophthalmologist, will join Clinique in its mission to educate consumers on the importance of eye safety, offer her ophthalmological expertise and guidance in the development of new products, and contribute to Clinique's dynamic educational content for consumers and Consultants.

Key Points: 
  • NEW YORK, Aug. 23, 2023 /PRNewswire/ -- With over five decades rooted in safety, Clinique, a dermatologist-developed prestige beauty brand, announces Ashley Brissette, MD, MSc, FRCSC, as the brand's first guiding ophthalmologist.
  • Since 1968, Clinique has been dedicated to delivering effective and safe formulas for consumers.
  • Dr. Brissette is an award-winning NYC ophthalmologist specializing in ocular surface diseases and cataract and laser corrective surgery.
  • The first campaign featuring Dr. Brissette will be for Clinique's New High Impact High-Fi™ Full Volume Mascara, launching this month.

Urology Care Foundation Announces 2023 Humanitarian Grant Recipients

Retrieved on: 
Tuesday, August 1, 2023
Kidney, COSECSA, American Urological Association, Patient, Erectile dysfunction, Health, Prostate cancer, University, Research, Children, Singal, Georgetown University School of Medicine, Urinary incontinence, University of Washington School of Medicine, Obstetrics, Hospital, Woman, FRCSC, Health education, Children's Hospital of Philadelphia, Incontinence, Michael Garron Hospital, Philadelphia, Medicine, Gynaecology, Urology, International Organization (journal), Microprocessor, Detroit Black Community Food Security Network, College, Education, Exelixis, Black, Surgeon, Bladder exstrophy, Health literacy, Nursing, Pharmaceutical industry, MD

BALTIMORE, Aug. 1, 2023 /PRNewswire/ -- The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce the 2023 Urology Care Foundation Humanitarian Grant recipients.

Key Points: 
  • BALTIMORE, Aug. 1, 2023 /PRNewswire/ -- The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce the 2023 Urology Care Foundation Humanitarian Grant recipients.
  • As one of the world's largest urology-specific humanitarian-focused grant programs, the Urology Care Foundation Humanitarian Grants aids the efforts of urologists and projects providing patient care and education in underserved areas, either within the United States or worldwide.
  • Fox Foundation Humanitarian Endowment, the Nathirmal N. Lalchandani Humanitarian Endowment, the Endourological Society Raju and Ginny Thomas Humanitarian Endowment, the Indian American Urological Association Humanitarian Endowment and from an Exelixis grant, and other contributors.
  • Learn more about the Urology Care Foundation Humanitarian Grant Program and the work of the 2023 grant recipients: https://www.urologyhealth.org/humanitarianism/humanitarian-recognition-a...

Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication

Retrieved on: 
Tuesday, June 6, 2023
Research, General Health, Technology, Clinical Trials, Science, Surgery, Nanotechnology, Biotechnology, Stem Cells, Other Science, Health, Diabetes, University of Alberta, FRCSC, Surgical oncology, University, AHS, MSM, Doctor of Philosophy, Organ transplantation, Cell Press, Cell Stem Cell, Canada Research Chair, Regenerative medicine, Blood, Cell, B cell, Immunosuppression, Medicine, Pharmaceutical industry, Dentistry

ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated from patient-derived iPSCS for the treatment and eventual cure of Type-1 Diabetes for publication in Cell Stem Cell , a peer-reviewed scientific journal published by Cell Press.

Key Points: 
  • ProtoKinetix, Incorporated ( www.protokinetix.com ) (the "Company" or "ProtoKinetix") (OTCQB: PKTX ), a clinical-stage biomedical company, today announced the submission of a research paper describing cell characterization, graft evaluation, and yield of islet-like cells differentiated from patient-derived iPSCS for the treatment and eventual cure of Type-1 Diabetes for publication in Cell Stem Cell , a peer-reviewed scientific journal published by Cell Press.
  • ProtoKinetix has been working alongside Dr. James Shapiro and his lab to improve the yield of protocols to generate islets from stem cells.
  • Importantly, in addition to increasing yield, AAGP® did not negatively affect the quality of islet products.
  • AAGP® treated cells maintained similar characteristics and function to untreated cells but had improved product yield.